Ford Motor Company vs Zoetis Inc — how do they compare? Ford Motor Company trades at $12.3 (market cap $48.33B), while Zoetis Inc trades at $73.02 (market cap $29.57B). The key difference: Ford Motor Company is the larger of the two by market cap, and Ford Motor Company pays the higher dividend (4.95%). Which is the better fit depends on your goals — on Pluang, investors hold Ford Motor Company for 104 Days and Zoetis Inc for 70 Days on average.
| F | ZTS | |
|---|---|---|
Market Cap | $48.33B | $29.57B |
Volume | 33,572,159 | 4,128,093 |
Sector | Consumer Cyclical | Health |
52-Week High | $17.44 | $147.53 |
52-Week Low | $11.21 | $69.09 |
Typical Hold Time | 104 Days | 70 Days |
Enterprise Value | $180.29B | $37.13B |
Dividend Yield | 4.95% | 2.96% |
Signals from Pluang's Aura AI — not financial advice
Ford Motor Company (F) trades at $12.125, down 1.22% with a bearish technical outlook. The company reported mixed quarterly results, beating Q1 and Q2 2026 EPS estimates but missing Q4 2025. Recent news highlights a 6.6% Q3 sales decline due to model phase-outs and supplier issues affecting F-150 production. Cash flow improved in 2025 with $560M net inflow, but profitability remains challenged with negative net income margin of -3.93% and ROE of -18.31%.
Ford faces headwinds from declining sales and profitability challenges, though analyst consensus remains cautiously optimistic with a $15.90 price target. The stock offers value with low P/S (0.26) and P/E (11.21) ratios, but investors must weigh competitive pressures and execution risks against potential turnaround opportunities in hybrid vehicle adoption and commercial divisions.
Zoetis (ZTS) trades at $71.55, showing modest daily gains of 0.32% amid a challenging market environment. The stock faces bearish technical signals with mixed quarterly earnings performance - beating expectations in Q2 2026 but missing in Q1. Strong fundamentals persist with 71.67% gross margins and 27.69% net income margins, though recent headwinds include U.S. companion animal market weakness and increased competition in key therapeutic areas. The company maintains robust cash flow generation with $2.9 billion from operations in 2025.
Despite near-term pressures, ZTS presents value opportunity with attractive valuation at 11.67 P/E ratio and consensus price target of $87.33 suggesting 22% upside. Risks include ongoing competitive pressures and U.S. market softness, but industry-leading profitability and international growth provide stability. Analyst sentiment remains positive with no sell ratings among 32 covering firms, though technical indicators suggest cautious near-term positioning.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Ford Motor Company designs, manufactures, and services cars and trucks. The Company also provides vehicle-related financing, leasing, and insurance through its subsidiary.
Read more on F →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →